(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

M. Maes; B. Leonard; A. Fernandez; M. Kubera; G. Nowak; R. Veerhuis; A. Gardner; P. Ruckoanich; M. Geffard; C. Altamura; P. Galecki; M. Berk

doi:https://doi.org/10.1016/j.pnpbp.2011.02.019

(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

M. Maes, B. Leonard, A. Fernandez, M. Kubera, G. Nowak, R. Veerhuis, A. Gardner, P. Ruckoanich, M. Geffard, C. Altamura, P. Galecki, M. Berk

Laboratory Medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

104 Citations (Scopus)

Original language	English
Pages (from-to)	659-663
Journal	Progress in Neuropsychopharmacology & Biological Psychiatry
Volume	35
Issue number	3
DOIs	https://doi.org/10.1016/j.pnpbp.2011.02.019
Publication status	Published - 2011

Access to Document

https://doi.org/10.1016/j.pnpbp.2011.02.019

Cite this

Maes, M., Leonard, B., Fernandez, A., Kubera, M., Nowak, G., Veerhuis, R., Gardner, A., Ruckoanich, P., Geffard, M., Altamura, C., Galecki, P., & Berk, M. (2011). (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors. Progress in Neuropsychopharmacology & Biological Psychiatry, 35(3), 659-663. https://doi.org/10.1016/j.pnpbp.2011.02.019

@article{bc8462d1b0b540a79b04fb08e1167d59,

title = "(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors",

author = "M. Maes and B. Leonard and A. Fernandez and M. Kubera and G. Nowak and R. Veerhuis and A. Gardner and P. Ruckoanich and M. Geffard and C. Altamura and P. Galecki and M. Berk",

year = "2011",

doi = "https://doi.org/10.1016/j.pnpbp.2011.02.019",

language = "English",

volume = "35",

pages = "659--663",

journal = "Progress in Neuropsychopharmacology & Biological Psychiatry",

issn = "0278-5846",

publisher = "Elsevier Inc.",

number = "3",

}

Maes, M, Leonard, B, Fernandez, A, Kubera, M, Nowak, G, Veerhuis, R, Gardner, A, Ruckoanich, P, Geffard, M, Altamura, C, Galecki, P & Berk, M 2011, '(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors', Progress in Neuropsychopharmacology & Biological Psychiatry, vol. 35, no. 3, pp. 659-663. https://doi.org/10.1016/j.pnpbp.2011.02.019

TY - JOUR

T1 - (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

AU - Maes, M.

AU - Leonard, B.

AU - Fernandez, A.

AU - Kubera, M.

AU - Nowak, G.

AU - Veerhuis, R.

AU - Gardner, A.

AU - Ruckoanich, P.

AU - Geffard, M.

AU - Altamura, C.

AU - Galecki, P.

AU - Berk, M.

PY - 2011

Y1 - 2011

U2 - https://doi.org/10.1016/j.pnpbp.2011.02.019

DO - https://doi.org/10.1016/j.pnpbp.2011.02.019

M3 - Article

C2 - 21376099

SN - 0278-5846

VL - 35

SP - 659

EP - 663

JO - Progress in Neuropsychopharmacology & Biological Psychiatry

JF - Progress in Neuropsychopharmacology & Biological Psychiatry

IS - 3

ER -